Nothing Special   »   [go: up one dir, main page]

EP2673023B1 - Dispositif de perfusion sous-cutané - Google Patents

Dispositif de perfusion sous-cutané Download PDF

Info

Publication number
EP2673023B1
EP2673023B1 EP12744352.1A EP12744352A EP2673023B1 EP 2673023 B1 EP2673023 B1 EP 2673023B1 EP 12744352 A EP12744352 A EP 12744352A EP 2673023 B1 EP2673023 B1 EP 2673023B1
Authority
EP
European Patent Office
Prior art keywords
catheter
introducer needle
skin surface
infusion device
septum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP12744352.1A
Other languages
German (de)
English (en)
Other versions
EP2673023A4 (fr
EP2673023A2 (fr
Inventor
Victor POLITIS
Gary Searle
Mark Guarraia
Joseph Gordon
Dave Zitnick
Sharon Mulligan
Ralph Sonderegger
Thomas Kluck
Joshua Horvath
Charles Hwang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Priority to EP19157528.1A priority Critical patent/EP3542852B1/fr
Publication of EP2673023A2 publication Critical patent/EP2673023A2/fr
Publication of EP2673023A4 publication Critical patent/EP2673023A4/fr
Application granted granted Critical
Publication of EP2673023B1 publication Critical patent/EP2673023B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • A61M2005/14252—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
    • A61M2005/1585—Needle inserters

Definitions

  • the present invention relates generally to insulin infusion systems, specifically an integrated inserter and infusion set for containing and placing a cannula, a pre-loaded inserter and infusion set for containing and placing a flexible catheter, and an inserter for containing and placing an infusion set with a retractable introducer needle, and wherein the catheter is isolated from movement after placement.
  • infusion therapy such as daily insulin infusions
  • the first mode includes syringes and insulin pens. These devices are simple to use and are relatively low in cost, but they require a needle stick at each injection, typically three to four times per day.
  • the second mode includes infusion pump therapy, which entails the purchase of an insulin pump that lasts for about three years. The initial cost of the pump can be significant, but from a user perspective, the overwhelming majority of patients who have used pumps prefer to remain with pumps for the rest of their lives. This is because infusion pumps, although more complex than syringes and pens, offer the advantages of continuous infusion of insulin, precision dosing and programmable delivery schedules. This results in closer blood glucose control and an improved feeling of wellness.
  • an infusion pump requires the use of a disposable component, typically referred to as an infusion set or pump set, which conveys the insulin from a reservoir within the pump into the skin of the user.
  • An infusion set typically consists of a pump connector, a length of tubing, and a hub or base from which an infusion needle or a flexible cannula extends.
  • the hub or base has an adhesive which retains the base on the skin surface during use, which may be applied to the skin manually or with the aid of a manual or automatic insertion device.
  • a user is further required to carry and provide a separate inserter. Accordingly, this method of treatment can become cumbersome and wasteful when dealing with the large number of required components.
  • Teflon-based cannula also referred to as a catheter
  • Teflon cannula are associated with less discomfort than steel cannulas.
  • soft cannulas are prone to kink, which can delay or interrupt the patient's insulin delivery and reduce therapy.
  • Most soft cannula infusion sets are inserted using a steel introducer needle that is positioned inside the cannula lumen and which extends beyond the cannula to initiate penetration. The introducer needle is then removed after catheter insertion.
  • Some infusion sets also use a separate high-impact, spring-loaded inserter that propels the introducer needle and cannula into the tissue at a desired speed, and to a desired depth.
  • This process results in numerous steps which can be required to insert the infusion set, since it often requires the user to carry a separate insertion device, and load a set into the insertion device each time.
  • the separate insertion device or inserter is therefore an added cost to the user and the additional steps of properly loading a device or set in the separate insertion device can become cumbersome.
  • most insulin infusion sets deliver medicament to the subcutaneous layers of skin using either rigid metal needles or flexible plastic cannulas.
  • most insulin infusion sets do not provide any features to isolate the inserted needle or cannula from shock or other external forces.
  • most insulin sets require separate inserters, which require the user to carry extra components for treatment. In regard to such separate inserters, an additional problem encountered by users of such separate inserters is the need to carry additional accessories and the difficulty of loading the infusion set onto the insertion device at each use.
  • an introducer needle, catheter, and adhesive are all deployed at substantially the same time when inserted.
  • WO 2008/133702 A1 discloses a needle inserting and fluid flow connection for an infusion medium delivery system.
  • An object of the present invention is to provide an integrated inserter and infusion set for containing and placing a catheter, while maintaining a degree of comfort to the user.
  • Another object of the present invention is to provide an integrated inserter and infusion set for containing and placing a flexible catheter.
  • Another object of the present invention is to provide a pre-loaded inserter for containing and placing an infusion set with a retractable introducer needle, wherein the catheter is isolated from movement after placement.
  • Another object of the present invention is to provide a device to place a catheter of an infusion set such that a user can attach the complete device to the skin surface and then deploy the catheter, thereby preventing any bunching of the adhesive when attached, as well as ensuring that the set hub is fully contacting the skin before the introducer needle is inserted.
  • Another object of the present invention is to provide a device to place a cannula or catheter of an infusion set such that the catheter is inserted at the correct depth.
  • Another object of the present invention is to provide a device to contain and place a catheter of an infusion set and retract the introducer needle back into the catheter by a short distance, to thereby provide structural support to the catheter and prevent kinking as well as shielding the surrounding tissue from the sharp introducer needle tip.
  • Another object of the present invention is to provide a device to contain and place a catheter of an infusion set using an automatic method of deployment such that the user only needs to push down the top of the device, such as a button disposed at or near the top of the device, to insert both the introducer needle and the catheter.
  • Another object of the present invention is to provide a pre-loaded device to contain and place a catheter of an infusion set using an automatic method of deployment such that the user only needs to push down the top of the device, such as a button disposed at or near the top of the device, to further activate the introducer needle retraction operation.
  • Another object of the present invention is to provide a device to contain and place a catheter of an infusion set such that partial retraction of the introducer needle back into the catheter after the catheter of the infusion set is inserted provides structural integrity while maintaining the desirable biocompatibility aspects of the soft catheter.
  • Another object of the present invention is to provide a device to contain and place a catheter of an infusion set using a stronger, more flexible catheter that prevents kinking as it is much stiffer than a conventional Teflon catheter.
  • Another object of the present invention is to provide a device to contain and place a catheter of an infusion set such that the introducer needle is hidden from the user prior to use and insertion, which makes the device more safe and appealing to users who are uncomfortable with needles.
  • Another object of the present invention is to provide a device to contain and place a catheter of an infusion set such that the catheter assembly is configured to "float" in the hub, which serves to isolate the catheter from external forces once in place and to dampen motion due to body movement or accidental bumps and/or tubing tugs.
  • an integrated inserter and infusion set for containing and placing a cannula
  • an integrated inserter and infusion set for containing and placing a flexible catheter
  • a pre-loaded inserter for containing and placing an infusion set with a retractable introducer needle, wherein the catheter is isolated from movement after placement.
  • the device comprises an infusion set and insertion device integrated into a single unit, thereby eliminating the need to carry any additional accessories and avoid the difficulty associated with loading the infusion set onto the insertion device at each use.
  • Fig. 1 is a perspective view of an exemplary device 10 utilizing an integrated inserter and set in accordance with a first embodiment of the present invention before deployment
  • Fig. 2 is a perspective view of the exemplary device of Fig. 1 after deployment.
  • the device 10 comprises a hub 20, having a user push button 30 to activate the device for catheter placement.
  • a catheter 40 can be extended from a bottom surface of the hub 20 during activation of the device.
  • Fig. 3 is a cross-sectional view of the exemplary device of Fig. 1 , illustrating the components thereof in greater detail.
  • the hub 20 comprises an opening at a top surface and in which the push button 30 is disposed.
  • the push button 30 is configured to slidably travel downward, substantially perpendicular to the skin surface, from an extended position as shown in Fig. 1 to a substantially flush position shown in Fig. 2 .
  • An outer dimension of the push button 30 is configured to be slidably received in a similar shaped opening in the top of the hub 20.
  • both the hub 20 and the push button 30 have a non-circular shape, but are not limited thereto.
  • the non-circular shape can be configured to facilitate offsetting the position of the catheter to one side of the device, resulting in less material where a viewing window can be located.
  • the hub 20 is configured to position the catheter and introducer needle offset to one side of the device 10, near a viewing window 28 provided in the housing of the hub 20.
  • the viewing window 28 can be provided as an opening in the hub 20, or as a clear and/or magnifying material to allow the user or others to view and monitor conditions of the insertion site such as redness and/or bleeding that can occur during use and which may require attention.
  • the hub 20 further comprises a tube connection port 42 to which an exemplary tube 44 can be connected to connect the infusion set with a medicament pump or other supply vessel.
  • An adhesive liner 34 can be provided to cover an adhesive layer 36, such as pressure sensitive adhesive (PSA), on the bottom of the device 10.
  • PSA pressure sensitive adhesive
  • the push button 30 comprises at least one projection 32 on a lower surface to slidably engage a similar opening 22 in the hub 20.
  • the push button 30 is configured to press a needle septum 24 and introducer needle 26 toward an insertion site when pressed by a user.
  • the introducer needle 26 enters and guides the catheter 40 for insertion and placement. As shown in Fig. 3 , the introducer needle 26 tip can then be retracted a slight distance back into the catheter 40. That is, the push button 30 is configured to move back up a small distance once the device is activated and to retract the introducer needle 26 with it.
  • the engagement between projection 32 and opening 22 can be configured to have a portion at an end stroke of the button 30 that biases the button 30 upward, to thereby retract the button 30 slightly when the user stops pressing the button 30.
  • This can be achieved by creating tapers or other engagement features to bias the button 30 or bias the needle septum 24 towards slight retraction when downward pressure on the button 30 is released.
  • the partial retraction of the introducer needle 26 back into the catheter 40 after the catheter 40 of the device 10 is inserted provides structural integrity while maintaining the desirable biocompatibility aspects of the soft catheter 40. Further, the tissue is shielded from the sharp introducer needle tip to reduce irritation at the infusion site.
  • Figs. 4A-4C are enlarged cross-sectional views of the exemplary device 10 of Fig. 1 illustrating the relation between the introducer needle 26 and catheter 40 during use.
  • the introducer needle 26 is disposed within an inner lumen of the catheter 40 and extends slightly at the exposed tip thereof.
  • the introducer needle 26 and catheter 40 are contained within the set as permitted by the button 30 in the pre-activation position.
  • the button 30 and is pressed and projection 32 of the button 30 moves downward, the needle septum 24, introducer needle 26, and catheter 40 are all advanced toward the insertion site until seated in a skin surface 45 as shown in Fig. 4B .
  • the introducer needle 26 is retracted slightly back into the catheter 40 (e.g., by about 1-3 mm) as shown in Fig. 4C .
  • the engagement between projection 32 and opening 22 is configured to have a portion at an end stroke of the button 30 that biases the button 30 to retract slightly when the user stops pressing the button 30.
  • the partial retraction of the introducer needle 26 back into the catheter 40 after the catheter 40 of the device 10 is inserted provides structural integrity while maintaining the desirable biocompatibility aspects of the soft catheter 40, and the tissue is shielded from the sharp introducer needle tip to reduce irritation at the infusion site.
  • Figs. 5A-5C are views of the exemplary device 10 of Fig. 1 in use.
  • a user removes the adhesive liner from the lower surface to expose the adhesive layer 36 on the bottom of the device 10.
  • the hub 20 of the device 10 is then secured to an infusion site using the exposed adhesive layer 36 as shown in Fig. 5B .
  • This ensures that the hub 20 of the device 10 is fully contacting and adhesively secured to the skin surface before the user performs the deployment of the introducer needle 26 and catheter 40.
  • the user presses the top button 30 of the device 10 to insert the introducer needle 26 and catheter 40 in a single motion as shown in Fig. 5C .
  • the button 30 then retracts slightly when the user stops pressing the button 30 resulting in a partial retraction of the introducer needle 26 back into the catheter 40.
  • the tube 44 can then be connected to a pump or other medicament supply.
  • the user can attach the complete device to the skin surface and deploy the catheter of the infusion set, preventing any bunching of the adhesive when attached, as well as ensuring that the set hub is fully contacting and adhesively secured to the skin before the introducer needle and catheter are inserted. This also ensures that the catheter is inserted at the correct depth.
  • the exemplary device then functions to retract the introducer needle back into the catheter a short distance, to thereby provide structural support to the catheter which prevents kinking as well as shielding the surrounding tissue from the sharp introducer needle tip.
  • the device uses a manual method of deployment as the user is required to push down the top of the device, such as a button disposed at or near the top of the device, to insert both the introducer needle and the catheter. Such an action can further activate the introducer needle retraction operation.
  • an introducer needle, catheter, and adhesive are all deployed at substantially the same time.
  • there is a high-speed contact of the adhesive pad while the introducer needle and the catheter are being inserted which may result in partially inserted catheters and/or incomplete adhesion.
  • the exemplary first embodiment of the present invention eliminates the potential of partial insertion of the catheter and/or incomplete adhesion, since the system and method first ensures that the hub of the set is fully contacting and adhesively secured to the skin surface, and then performs the deployment of the introducer needle and catheter with full control as the user pushes the catheter and introducer needle both into the skin using a manual push button operation.
  • Release of the button permits the partial retraction of the introducer needle back into the catheter after the catheter of the infusion set is inserted to provide structural integrity while maintaining the desirable biocompatibility aspects of the soft catheter. In doing so, the tissue is shielded from the sharp introducer needle tip to reduce irritation at the infusion site.
  • the exemplary first embodiment of the present invention significantly reduces the steps required to insert the catheter of the infusion set since the user is not required to load an infusion set into an inserter device. Further, the introducer needle is hidden from the user prior to use and insertion which makes the device more safe and appealing to users who are uncomfortable with needles.
  • the exemplary first embodiment of the present invention is configured to allow the user to attach the device to the skin surface in a first step, deploy the introducer needle and catheter in a second step thereby preventing any bunching of the adhesive when attached as well as ensuring that the set hub is fully contacting and adhesively secured to the skin before the introducer needle is inserted, and retract the introducer needle slightly in a third step by releasing the button. This also ensures that the catheter is inserted at the correct depth. Further, since the catheter and the introducer needle are preferably offset to one side of the device, the viewing window allows the user or others to view and monitor conditions of the insertion site such as redness and/or bleeding that can occur during use and which may require attention.
  • the device comprises another infusion set and insertion device integrated into a single unit, thereby again eliminating the need to carry any additional accessories and avoid the difficulty associated with loading the infusion set onto the insertion device at each use.
  • Figs. 6 and 7 are views of an exemplary device 50 utilizing an integrated inserter and set in accordance with a second embodiment of the present invention.
  • the device 50 comprises a hub 60, from which a user push button 70 extends.
  • An in-dwelling, flexible cannula 80 can be extended from a bottom surface of the hub 60 during activation of the device.
  • Fig. 8 is a cross-sectional view of the exemplary device of Fig. 6 , illustrating the components thereof in greater detail.
  • Fig. 9 is a view of the exemplary in-dwelling cannula 80 used in this embodiment, comprising a flexible, skin-piercing needle or catheter that does not require a separate introducer needle.
  • the hub 60 comprises an opening at a side surface and in which the push button 70 is disposed.
  • the push button 70 is configured to slidably travel substantially parallel to a skin surface from an extended position to a substantially flush position shown.
  • An outer dimension of the push button 70 is configured to be slidably received in a similar shaped opening in the side of the hub 60.
  • the hub 60 has a non-circular shape, but is not limited' thereto.
  • the shape of the device can be configured in any number of shapes to hold the flexible needle while it is in the device.
  • a circular hub can be provided to coil the flexible needle therein before use.
  • the hub 60 further comprises a curved needle or catheter path 68 such that the movement of the push button 70 substantially parallel to a skin surface from an extended position to a substantially flush position, can be used to insert the flexible needle or catheter 80.
  • the flexible catheter 80 is configured to flex and be guided along the curved catheter path 68 from a position substantially parallel to a skin surface to a position substantially perpendicular to a skin surface for insertion at a site as directed by the push button 70.
  • the hub 60 further comprises a tube connection port 62 to which an exemplary tube 64 can be connected to connect the infusion set with a medicament pump or other supply vessel.
  • An adhesive liner 74 can be provided to cover an adhesive layer 76, such as a pressure sensitive adhesive (PSA), on the bottom of the device 10.
  • PSA pressure sensitive adhesive
  • the push button 70 comprises at least one projection 72 on a surface to slidably engage a similar opening 64 in the hub 60.
  • the push button 70 is configured to press a septum 66 and flexible catheter 80, such that the flexible catheter 80 is pushed along the curved catheter path 68 toward an insertion site when pressed by a user.
  • An exemplary flexible stainless-steel, in-dwelling, needle or catheter 80 is shown in Fig. 9 .
  • the in-dwelling cannula 80 used in this embodiment is a flexible, skin-piercing needle or catheter that does not require a separate introducer needle.
  • the body of the flexible catheter 80 comprises one or more features to create substantially flexible body segment(s).
  • an entire length of the catheter can be flexible, but embodiments are not limited thereto.
  • the one or more features to create the substantially flexible, body segment(s) comprise a slotted structure which allows the shaft to be flexible, maintain column strength, but allow insertion when for example, guided through a curved path.
  • the one or more features to create the substantially flexible body segment(s) comprise a series of hoops or coils, wherein the strength of the catheter 80 is maintained and prevents collapse of the inner lumen.
  • the slots, hoops, coils or other features can be laser cut, chemically etched or otherwise created, in an alternating or other pattern, and the body or portions thereof can then be covered with a sleeve.
  • Exemplary flexible catheters are described in co-pending U.S. Patent Application Serial Nos. 13/138,128 , 12/585,061 , and 12/585,062 , the entire contents of which are incorporated herein by reference.
  • the alternating slots or coils surround a lumen and enable the needle or catheter 80 to flex to provide a comfortable in-dwelling catheter, but also provide a rigidity or column strength necessary for insertion into the user's skin.
  • the exemplary flexible needle or catheter 80 is preferably a unitary body 82 of a material such as stainless steel, having a sharpened, self-piercing tip 84 at the distal end.
  • the sharpened, self-piercing tip 84 can comprise a radius cut to create a beveled tip.
  • the catheter 80 is provided with such a sharpened, self-piercing tip 84 to allow the insertion, the catheter can act as an introducer needle, thereby further reducing the complexity of the insertion step.
  • the catheter 80 can be sheathed or coated over some desired portion by a coating 86, such as a VialonTM coating or a TeflonTM coating, to create a sleeve that provides a biocompatible outer fluid seal for enabling a drug fluid to enter to the user through the tip of the catheter 80, provides a seal so that leakage does not occur through the slots, and/or provides a cover into which the self-piercing tip 84 can be slightly retracted to cover the sharpened end thereof.
  • a coating 86 such as a VialonTM coating or a TeflonTM coating
  • the attachment of the sheath or coating can be facilitated by a dip coating process, heat shrinking, bonding, or any other suitable process.
  • any suitable fluid tight material could be used to form the sheath or coating, such as a flexible sleeve or over-molded coating/sleeve.
  • a material which can become softer and/or more flexible once inserted can advantageously be used.
  • Figs. 10A-10E are views of the exemplary device 50 of Fig. 6 in use.
  • a user removes the adhesive liner 74 from the lower surface to expose the adhesive layer 76 of the bottom of the device 50.
  • the flexible catheter 80 is retracted into the hub 60 and the push button 70 is in an extended position.
  • the hub 60 of the device 50 can then be secured to an infusion site using the exposed adhesive layer 76 as shown in Fig. 10B . This ensures that the hub 60 of the device 50 is fully contacting and adhesively secured to the skin surface before the user performs the deployment of the catheter 80.
  • the user can then press the button 70 of the device 50 to insert the catheter 80 in a single motion as shown in Fig. 10C .
  • the tube 64 can then be connected to a pump or other medicament supply.
  • the push button 70 can be configured to secure the tube 64 to the device, such that pressing the button 70 permits removal of the tube 64 as shown in Fig. 10E .
  • the push button 70 and projection 72 can engage one or more detents (not shown) of the tube 64 connector such that the tube connector and tube 64 cannot be removed from the connection port 62 if the button 70 is in a first position, and can be removed when the button 70 is in a second position.
  • the user can attach the complete device to the skin surface and then deploy the in-dwelling catheter of the infusion set preventing any bunching of the adhesive when attached as well as ensuring that the set hub is fully contacting and adhesively secured to the skin before the in-dwelling catheter is inserted. This also ensures that the in-dwelling catheter is inserted at the correct depth.
  • the exemplary device further provides a flexible steel in-dwelling catheter that can prevent kinking, since it is much stiffer than a conventional Teflon catheter.
  • the device uses a manual method of deployment as the user is required to push the side of the device, such as a button disposed at the side of the device, to insert the in-dwelling catheter.
  • an introducer needle, catheter, and adhesive are all deployed at substantially the same time.
  • there is a high-speed contact of the adhesive pad while the introducer needle and the catheter are being inserted which may result in partially inserted catheters and/or incomplete adhesion.
  • the exemplary second embodiment of the present invention eliminates the potential of partial insertion of the catheter and/or incomplete adhesion, since the system and method first ensures that the hub of the set is fully contacting and adhesively secured to the skin surface and then performs the deployment of the catheter with full control as the user pushes the catheter into the skin using a manual push button operation.
  • the stronger, more flexible catheter completely prevents kinking as it is much stiffer than a conventional TeflonTM catheter.
  • the exemplary second embodiment of the present invention significantly reduces the steps required to insert the infusion set since the user is again not required to load the infusion set into the inserter device. Further, the flexible catheter including sharpened tip is hidden from the user prior to use and insertion, which makes the device more safe and appealing to users who are uncomfortable with needles.
  • the device is configured for the user to attach the device to the skin surface in a first step, then deploy the flexible catheter in a second step, thereby preventing any bunching of the adhesive when attached as well as ensuring that the set hub is fully contacting and adhesively secured to the skin before the flexible catheter is inserted. This also ensures that the catheter is inserted at the correct depth.
  • the provision of a stronger, more flexible catheter substantially eliminates kinking, as it is much stiffer than a Teflon catheter.
  • the device comprises another infusion set and insertion device integrated into a single unit, thereby again eliminating the need to carry any additional accessories and avoid the difficulty associated with loading the infusion set onto the insertion device at each use.
  • Figs. 11 and 12 are views of an exemplary device 100 utilizing an integrated inserter and set in accordance with a third embodiment of the present invention.
  • the device 100 comprises an upper housing 160, from which a user release trigger 170 extends.
  • the upper housing 160 is secured to a lower housing 180, and an in-dwelling cannula 162 can be extended from a bottom surface of the lower housing 180 during activation of the device.
  • Fig. 13 is an exploded view of the exemplary device of Figs. 11 and 12 , illustrating the components thereof in greater detail.
  • Fig. 14 is a view of the feature movements occurring during placement of the in-dwelling cannula 162.
  • the upper housing 160 comprises an opening at a side surface and in which the user release trigger 170 is disposed.
  • the user release trigger 170 is provided as a cantilevered portion of the upper housing 160, secured at one end and free at an opposite end, and having a raised portion at the free end for user engagement.
  • the user release trigger 170 is configured to deflect a spring retainer 168 and release a driving coil spring 166 contained in the upper housing 160.
  • the upper housing 160 contains therein a rotatable cam ring 164, spring 166, spring retainer 168 and cam surface 172.
  • the rotatable cam ring 164 is configured to rotate relative to the upper housing 160 as urged by the spring 166 once released by the spring retainer 168.
  • the lower housing 180 is formed with a cam ring guide 174 to rotatably guide a lower edge of the cam ring 164.
  • a reciprocal guide can be formed in the surface of the upper housing 160 to guide a top edge of the cam ring 164.
  • an inclined cam surface 172 of the rotating cam ring 164 engages a cannula head 176 of a cannula 162.
  • the cannula 162 is prevented from rotating with the cam ring 164 by placement of the cannula 162 in a C-shaped guide feature 178 extending perpendicular to a surface of the lower housing 180.
  • the rotating motion of the cam ring 164 is translated into a linear motion of the cannula 162 in the guide feature 178 to drive the cannula 162 into placement through a guiding septum 184.
  • the cam ring 164 movement is stopped by a cam stop 182 coinciding with desired cannula 162 placement depth.
  • the device 100 has a circular shape, but is not limited thereto.
  • the shape of the device can be configured in any number of shapes, but having a circular portion to permit cam ring rotation.
  • a line or extension set 186 can then be attached to the upper or lower housing, or as shown in Fig. 13 , can be manufactured with the lower housing 180, and can be connected to a medicament pump or other supply vessel.
  • An adhesive liner 185 can be provided to cover an adhesive layer 188, such as a pressure sensitive adhesive (PSA), on the bottom of the device.
  • PSA pressure sensitive adhesive
  • the third exemplary embodiment provides a low-profile assembly that is part of an insulin infusion set.
  • the low-profile assembly incorporates a rigid steel needle that remains in-dwelling and is deployed to a depth of preferably 4.0 mm to 4.5 mm into the surface of the skin, i.e. 1.0 mm to 1. 5 mm into subcutaneous tissue.
  • the overall height of the assembly is preferably 3.8 mm higher than the deployment depth (i.e., for subcutaneous deployment to a depth of 4.5 mm, the profile is 8.3 mm, and for intradermal deployment to a depth of 1.5 mm, the profile is 5.3 mm).
  • the overall height of the assembly is 6.5 mm, and the necessary mechanization for deployment and structural components of the assembly increase the overall height of the assembly by preferably 2.5 mm beyond the deployment depth.
  • the overall height of the assembly is preferably 4.0 mm, i.e. 1.5 mm into tissue plus preferably 2.5 mm for mechanization and structural components.
  • the elements can be thinned and incorporate a splined collar over the introducer needle to advance the needle from the side instead of from above with the cam ring as described above.
  • the in-dwelling steel cannula 162 is preferably straight with a cross-port 192 to allow insulin to flow from a septum cavity into the cannula.
  • the shouldered head 176 is attached to the top end of the cannula 162 to block flow from the top end and to also provide a contact surface for the cam surface 172 of the cam ring 164 to drive the cannula 162 into the tissue.
  • Slots can be machined into the rigid in-dwelling steel needle in the area of the skin interface, device interface or elsewhere, using laser machining, chemical etching, electrical discharge machining, or other metal removal processes, to render that portion of the rigid cannula flexible, thereby reducing or eliminating the effects of transferring motion through the sharp tip of the cannula to the tissue.
  • a thin-walled (i.e., 0.0005 inch thick) sleeve of tubing such as Teflon shrink tubing or another heat shrinkable tubing material, can be shrunk onto the in-dwelling flexible steel needle above and below the slotted area.
  • Figs. 15A-15D are views of the exemplary device 100 of Fig. 11 in use.
  • a user removes the adhesive liner from the lower surface to expose the adhesive layer 188 of the bottom of the device.
  • the cannula 162 is retracted into the lower housing 180.
  • the device 100 is then secured to an infusion site using the exposed adhesive layer 188. This ensures that the device 100 is fully contacting and adhesively secured to the skin surface before the user performs the deployment of the cannula 162.
  • the user presses the user release trigger 170 of the device 100 to release the rotating cam ring 164 to insert the cannula 162 in a single motion as shown in Fig. 15B and 15C .
  • a final position is shown in Fig. 15D . If not already connected, the tube 186 can then be connected to a pump or other medicament supply.
  • the third exemplary embodiment can further provide a small footprint, preferably about 14.2 mm in diameter, permitting the use of a strain relief feature, which can extend the use duration of an infusion set.
  • a strain relief feature which can extend the use duration of an infusion set.
  • the complete footprint of device and strain relief feature can be approximately the size of currently available infusion sets.
  • Exemplary strain relief features are described in co-pending U.S. Provisional Patent Application Serial No. 61/441,278 , the entire contents of which are incorporated herein by reference.
  • Fig. 16 is a perspective view of a strain-relief that can be provided with the exemplary device of Fig. 11 in use.
  • the device 100 can be coupled with the line set via an attachment 190 that can comprise an accordion tube connection 192 between the attachment 190 and the device 100.
  • the attachment 190 can further comprise a separate adhesive layer 194 to adhesively secure the attachment to the skin surface.
  • the adhesive layer 194 can be connected to the adhesive layer of the device either directly, or via an accordion shaped adhesive segment matching the tubing section 192.
  • the same adhesive cover can be provided for both layers 188 and 194.
  • the cam ring, cam surface, cannula and cannula head can be modified to utilize an introducer needle to deploy a catheter. Similar to the in-dwelling steel needle described above, the introducer needle could be rendered flexible in the area of the device interface or tissue interface to allow the introducer needle to remain in-dwelling. Alternately, the cam ring, cam surface, cannula and cannula head can be modified to allow the introducer needle to be either partially retracted such that the sharp tip of the introducer needle is retracted within the tip of the catheter, or completely retracted such that the introducer needle is retracted within the body of the hub. For all alternative embodiments the overall height of the assembly can be maintained at preferably 2.5 mm greater than the deployment depth.
  • Fig. 17 is an exploded view of the exemplary device of Fig. 11 illustrating alternative spring and cannula types in greater detail.
  • the device 150 can comprise an upper housing 102, release trigger 104 and lower housing 106 substantially as described in regard to the embodiment above, including an adhesive liner 125 that can be provided to cover an adhesive layer 126, such as a pressure sensitive adhesive (PSA), on the bottom of the device 150.
  • a torsion spring 108 is disposed within the upper housing 102 to surround a rotatable cam ring 112. The torsion spring 108 exhibits different performance characteristics as compared to the coil spring 66 in the embodiment above.
  • the rotatable cam ring 112 is configured to rotate relative to the upper and lower housings as urged by the torsion spring 108 when released by the trigger 104.
  • Upper and lower spring retainer detents 114 are provided on the cam ring 112 to hold the ends of the torsion spring during operation.
  • the spring can be eliminated entirely, and replaced with an external driving unit to drive the cam ring.
  • a pre-charged driver can be used to engage the cam ring using, for example, keys on an outer diameter, to rotate the cam ring for desired operation.
  • the lower housing 106 includes a cam ring guide 118 to rotatably guide the cam ring 112 during operation.
  • a reciprocal guide can be formed in the surface of the upper housing 102 to guide a top edge of the cam ring 112.
  • the lower housing 106 further includes a C-shaped guide feature 122 to guide in this case, an introducer needle 132 having a cannula head 128 to place a cross-ported catheter 134 through a septum 124 in the lower housing 106.
  • the device comprises a 28 gauge catheter, having a cross-port 136 at an upper portion thereof, and a 31 gauge introducer needle, but is not limited thereto.
  • Figs. 18A and 18B are enlarged views illustrating an operation of the exemplary device of Fig. 17 .
  • the release of the torsion spring 108 can be used to rotate the cam ring 112 which can direct movement of the introducer needle 132 and catheter 134 by directing movement of the cannula head 128 using the cam surface 116.
  • the cam surface 116 is configured to move the cannula head 128 to first drive the introducer needle 132 and catheter 134 through the septum 124 in the lower housing 106 and into a skin surface. Further movement of the cam ring 112 and the cam surface 116 is configured to move the cannula head 128 to either partially or fully retract the introducer needle 132 into the lower housing 106.
  • the overall height of the device can be preferably 8.3 mm as a result of recessing the introducer needle inside the assembly.
  • an upper housing can be provided with a thickness of 0.75 mm
  • a portion of the cam ring that extends above the cannula head can be 0.4 mm
  • a cannula head thickness can be 0.4 mm
  • a distance for the cannula cross-port to the cannula head can be 0.4 mm.
  • a distance from the cross-port to the bottom of the septum can be 0.4 mm
  • an adhesive thickness can be 0.1 mm.
  • a gap from the tip of the introducer needle to the far side of the adhesive can be 0.25 mm, and the tip of the introducer needle can extend 1.1 mm, for a total of 3.8 mm. Further reduction in the overall height can be accomplished by assembling the introducer needle to extend from the adhesive by 1 mm to 2 mm without affecting use. Further, a cam ring having two or more stages can be used to reduce the height and component thickness above the cannula head.
  • a common misuse failure occurs when deployment is incomplete and the user then wipes or otherwise presses the hub or patch to the skin surface causing either the catheter to kink, the depth of deployment to be shallow, or both.
  • the third exemplary embodiment prevents such misuse failures by providing the adhesive which secures the device to the surface of the skin, and then providing the deployment of the cannula by a separate motion and mechanization.
  • the assembly of the third embodiment is smaller than most currently marketed assemblies which do not incorporate an inserter.
  • Lower height relates to less physical interference with obstacles potentially resulting in less transfer of motion and improved comfort for the patient.
  • the reduced footprint also equates to improved comfort.
  • integrated inserters typically increase the complexity of the mechanization in the assembly, making the devices prone to failure and user error.
  • only two extra components are added to provide the integrated insertion function. Either a bottom up or top down assembly process (i.e., an assembly sequence in which the components can be stacked from either the lower or upper housing) can be used. A single production line can be utilized, and use carryover components with less development time for each.
  • This embodiment provides the ability to use a rigid in-dwelling needle for subcutaneous infusion, a flexible in-dwelling needle with heat shrinkable sleeve for subcutaneous infusion, a rigid in-dwelling needle for intradermal infusion, and a flexible in-dwelling needle with heat shrinkable sleeve for intradermal infusion.
  • a catheter with flexible introducer needle, both fully deployed, can be provided.
  • the cam ring, cam surface, cannula and cannula head can be modified to retract such an introducer needle either partially or completely to reduce or eliminate the effects of motion on the tissue at the infusion site.
  • Any in-dwelling steel needle and introducer can also be rendered flexible to reduce or eliminate the effects of motion on the tissue at the infusion site. Accordingly, the third embodiment provides the desired functions while having a lower profile, smaller footprint, less complexity, and lower cost than assemblies of competitive products.
  • the device comprises another infusion set and insertion device integrated into a single unit, thereby again eliminating the need to carry any additional accessories and avoid the difficulty associated with loading the infusion set onto the insertion device at each use.
  • Fig. 19 is a view of an exemplary device 200 utilizing an integrated inserter and set in accordance with a fourth embodiment of the present invention and Fig. 20 shows the components therein in greater detail.
  • the device 200 comprises an upper housing 210, from which a button 220 extends.
  • the upper housing 210 is secured to a base 230.
  • a catheter assembly 240 having a catheter septum 242, catheter 244 and introducer needle 246 are held in an up and retracted position by the contact friction of the introducer needle 246 within the catheter 244.
  • the base 230 can further provide an opening 232 that surrounds a travel path of the catheter septum 242 to thereby guide the catheter septum 242 during insertion of the catheter 244 and introducer needle 246.
  • the opening 232 can further provide seals 234 to seal perforations of the catheter septum 242, and at least one fluid channel 236 as described in greater detail below.
  • the upper housing 210 comprises an opening at a side surface and in which an end of a torsion spring 212 engages an upper housing sear 214 to prevent rotation of the torsion spring 212.
  • the button 22 comprises an activation surface 216 to press the end of the torsion spring 212 free of the sear 214 to permit rotation of the torsion spring 212.
  • the upper housing 210 further comprises a rotary needle hub 216 through which the end of the torsion spring extends and which is configured to rotate relative to the upper housing 210 when the end of the torsion spring 212 is pushed free of the sear 214 to permit rotation of the torsion spring 212.
  • the rotary needle hub 216 comprises a rotary needle hub follower pin 218 which is configured to travel within a track 222 on an inner surface of the upper housing 210.
  • the track 222 has two sections.
  • An insertion track profile 224 is provided to move the rotary needle hub 216 including catheter septum 242, catheter 244 and introducer needle 246 toward the skin surface, and a retraction track profile 226 is provided to move the rotary needle hub 216 and introducer needle 246 away from the skin surface, leaving the catheter septum 242 and catheter 244 in the down position.
  • a retraction track profile 226 is provided to move the rotary needle hub 216 and introducer needle 246 away from the skin surface, leaving the catheter septum 242 and catheter 244 in the down position.
  • the rotating motion of the rotary needle hub 216 is translated into a linear motion of the catheter septum 242, catheter 244 and introducer needle 246 to drive the catheter 244 and introducer needle 246 into placement.
  • the device 200 has a circular shape, but is not limited thereto.
  • the shape of the device can be configured in any number of shapes, but having a circular portion to permit cam ring rotation.
  • a line set 202 can then be attached to the upper housing 210, or as shown in Fig. 19 , can be manufactured with the upper housing 210, and can be connected to a medicament pump or other supply vessel.
  • An adhesive liner 205 can be provided to cover an adhesive layer 204, such as a pressure sensitive adhesive (PSA), on the bottom of the device.
  • PSA pressure sensitive adhesive
  • the rotary needle hub follower 218 is engaged in the cam track 222.
  • the torsion spring 212 is released from the upper housing sear 214, the spring imparts a torque on the rotary needle hub 216 causing it to rotate.
  • the rotary needle hub follower 218, secured to the rotary needle hub 216 initially follows the cam track needle insertion profile 224, moving the catheter septum 242, catheter 244 and introducer needle 246 downward, penetrating the patient's skin as depicted in Figs. 22 and 23 .
  • the rotary needle hub follower 218 enters the cam track needle retraction profile 226, withdrawing the rotary needle hub 216 and the introducer needle 246 from the patient's skin, as shown in Figs. 24 and 27 .
  • the catheter septum 242 and catheter 244 remain in the base 230, either by the frictional force imparted by the seals 234 of opening 232 or by some other means of latching.
  • the introducer needle 246 can be fully or partially withdrawn, depending on the shape of the track 222 profile.
  • a fluid path is created as shown in Figs. 25-27 .
  • the catheter septum 242 comprises a number of septum perforations 248 as shown in Fig. 22 .
  • the perforations 248 of the catheter septum 242 are sealed above and below the channel 236 by the seals 234. Fluid enters the base 230 via the lumen 206 of the tube set 202, passes through the channel 236 and into a cavity created by the seals 234 and outer body of the septum, then through the septum via the septum perforations 248, and enters the catheter 244 via the catheter perforations 252.
  • a user removes the adhesive liner from the lower surface to expose the adhesive layer 204 of the bottom of the device.
  • the rotary needle hub 216, catheter septum 242, catheter 244 and introducer needle 246 are retracted into the upper housing 210 and the button 220 is in an extended position.
  • the device 200 can then be secured to an infusion site using the exposed adhesive layer 204. This ensures that the device 200 is fully contacting and adhesively secured to the skin surface before the user performs the deployment of the rotary needle hub 216, catheter septum 242, catheter 244 and introducer needle 246.
  • the user can then press the button 220 of the device 200 to release the torsion spring 212 from the upper housing sear 214 and drive the rotary needle hub 216, catheter septum 242, catheter 244 and introducer needle 246 into position.
  • the continued torsion spring 212 movement drives the rotary needle hub 216 and introducer needle 246 into a retracted position If not already connected, the tube 202 can then be connected to a pump or other medicament supply.
  • the device comprises another infusion set and insertion device integrated into a single unit, thereby again eliminating the need to carry any additional accessories and avoid the difficulty associated with loading the infusion set onto the insertion device at each use.
  • Fig. 28 is a view of an exemplary device 300 utilizing an integrated inserter and set in accordance with a fifth embodiment of the present invention and Fig. 29 shows the components therein in greater detail.
  • the device 300 comprises an upper housing 310, from which a button 320 extends.
  • the upper housing 310 is secured to a base 330.
  • a needle hub assembly 340 having a catheter septum 342, catheter 344 and introducer needle 346 are held in an up and retracted position by the contact friction of the introducer needle 346 within the catheter 344.
  • the catheter septum 342, catheter 344 and introducer needle 346 are substantially the same as described in regard to the fourth embodiment above.
  • the base 330 can further provide an opening 332 that surrounds a travel path of the catheter septum 342 to thereby guide the catheter septum 342 during insertion of the catheter 344 and introducer needle 346.
  • the opening 332 can further provide seals 334 to seal perforations of the catheter septum 342, and at least one fluid channel 336 as described in greater detail below.
  • the opening 332, seals 334 and fluid channel 336 are substantially the same as described in regard to the fourth embodiment above.
  • the upper housing 210 comprises an opening in a top surface to slidably receive the push button 320, which is captured within the upper housing by shoulders 322.
  • the needle hub 340 is slidably disposed within the button 320 and captures a needle hub retraction spring 324 between the needle hub 340 and a needle hub base 326.
  • the needle hub 340 is releasably secured to openings 338 of the needle hub base 326 by one or more safety spring retention latches 328, and wherein the needle hub retraction spring 324 is held in a compressed state between the needle hub 340 and the needle hub base 326.
  • the base 330 further comprises a cantilevered button retention latch 336 to capture the button 320 upon complete activation.
  • the device 300 has a circular shape, but is not limited thereto. The shape of the device can be configured in any number of shapes.
  • a line set 302 can then be attached to the upper housing 310 or base 330, or can be manufactured with the base 330, and can be connected to a medicament pump or other supply vessel.
  • An adhesive liner 305 can be provided to cover an adhesive layer 304, such as a pressure sensitive adhesive (PSA), on the bottom of the device.
  • PSA pressure sensitive adhesive
  • the needle hub 340, catheter septum 342, catheter 344 and introducer needle 346 are moved downward, penetrating the patient's skin as depicted in Fig. 30 .
  • the shoulder 322 of the button 320 is captured in the down position by the button retention latches 336.
  • detents of the safety spring retention latches 328 contact and are deflected by the opening 332 of the base 330 as shown in the enlarged view of Fig. 30A .
  • the needle hub 340 and introducer needle 346 are urged upward by the needle hub retraction spring 324 as shown in Fig. 31 .
  • the catheter septum 342 and catheter 344 remain in the base 330, either by the frictional force imparted by the seals 334 of opening 332 or by some other means of latching.
  • the introducer needle 346 can be fully or partially withdrawn, depending on the shape of the spring 324.
  • a fluid path is created as shown in Fig. 31 .
  • the catheter septum 342 comprises a number of septum perforations 348 as shown in Fig. 29 .
  • the perforations 348 of the catheter septum 342 are sealed above and below the channel 336 by the seals 334.
  • a user removes the adhesive liner from the lower surface to expose the adhesive layer 304 of the bottom of the device.
  • the needle hub 340, catheter septum 342, catheter 344 and introducer needle 346 are retracted into the upper housing 310 and the button 320 is in an extended position.
  • the device 300 can then be secured to an infusion site using the exposed adhesive layer 304. This ensures that the device 300 is fully contacting and adhesively secured to the skin surface before the user performs the deployment of the needle hub 340, catheter septum 342, catheter 344 and introducer needle 346.
  • the user can then press the button 320 of the device 300 to drive the needle hub 340, catheter septum 342, catheter 344 and introducer needle 346 into position.
  • the needle hub retraction spring is released and drives the needle hub 340 and introducer needle 346 into a retracted position
  • the needle hub 340 is driven upward against the upper interior of the button 320, such that the introducer needle tip is now drawn up inside of the catheter tip, thus shielding the needle tip.
  • the tube 302 can then be connected to a pump or other medicament supply.
  • a lower profile can also be a function of catheter insertion.
  • an insertion operation can be used to actually reduce a profile of the assembly.
  • the device comprises another infusion set and insertion device integrated into a single unit, thereby again eliminating the need to carry any additional accessories and avoid the difficulty associated with loading the infusion set onto the insertion device at each use.
  • Fig. 32 is a view of an exemplary device 400 utilizing an integrated inserter and set in accordance with a sixth embodiment of the present invention and Fig. 33 shows the components therein in greater detail.
  • the device 400 comprises an upper housing 430, secured to a base 440.
  • the upper housing 430 is constructed as a "bellows" shaped, collapsible body, wherein the shape allows the upper housing to be easily compressed into a smaller space.
  • a catheter assembly 432 having a catheter septum 434, catheter 436 and introducer needle 438 are held in an up and retracted position between the upper housing 430 and detents 442 of body retention latches 444 of the base 440.
  • the base 440 can further provide a catheter retention latch 446, wherein the latches 444 and 446 can surround a travel path of the catheter septum 434 to thereby guide, and subsequently capture, the catheter septum 434 during insertion of the catheter 436 and introducer needle 438.
  • the upper housing 430 serves to contain most of the major components, and as a function of its bellows shape, can be compressed during insertion of the catheter 436 and introducer needle 438, and function as a spring to expand again toward its original shape for introducer needle 438 retraction after placement of the catheter 436.
  • a line set 428 can then be attached to the upper housing, or as shown in Fig. 33 , can be manufactured with the upper housing 430, and can be connected to a medicament pump or other supply vessel.
  • An adhesive liner 445 can be provided to cover an adhesive layer 448, such as a pressure sensitive adhesive (PSA), on the bottom of the device.
  • PSA pressure sensitive adhesive
  • Figs. 32-36 illustrating an exemplary use of the sixth embodiment
  • the device when the device is adhesively secured to a skin surface as shown in Fig. 33 and the upper housing 430 top surface is pressed toward the skin surface as shown in Fig. 34 , it is compressed from its initial shape to a reduced shape.
  • the upper housing 430 presses the catheter assembly 432 past the detents 442 of the body retention latches 444 of the base 440, and finally into the catheter retention latches 446 that surround the travel path of the catheter septum 434 during insertion of the catheter 436 and introducer needle 438.
  • detents of the catheter retention latches 446 grasp and retain the catheter assembly 432 as shown in Fig. 34 , maintaining the position of the catheter assembly in the down position, such that the catheter 436 and introducer needle 438 are at this time held in the patient's skin.
  • the integral spring nature of the upper housing 430 attempts to return the upper housing to its initial shape as shown.
  • the catheter retention latches 446 continue to hold the catheter assembly 432 in position, but the introducer needle 438 is secured to the upper housing 430 and is slidably disposed within the catheter 436. Accordingly, as the upper housing 430 attempts to return to an original shape, the introducer needle 438 is retracted some distance within the catheter 436 which remains in position with the catheter assembly 432.
  • the upper housing 430 returns to an original shape to the extent permitted by the body retention latches 444.
  • the upper housing 430 comprises openings 452 through which the body retention latches 444 pass when the upper housing 430 is pressed downward.
  • the detents 442 of the body retention latches 444 are captured by shoulders 454 to halt further upward motion of the upper housing 430 as shown in Fig. 36 .
  • the integral nature of features in the upper housing 430 and base 440 provide mechanisms without adding additional parts or assembly thereof. These mechanisms are provided by the body retention latches 444, catheter retention latches 446, and the integral spring action that results from the bellows shape of the upper housing 430. Elimination of parts also has potential to minimize the size of the device.
  • the upper housing 430 and openings 452 can be configured to conceal any protrusion by the body retention latches 444 so that they will not interfere with the user's fingers when they are in the protruded position shown in Fig. 34 .
  • the body retention latches 456 can extend downward to capture lower body retention latches 458 thereby eliminating any protrusion of the latches during activation, while achieving the same effect as described above.
  • the device comprises another infusion set and insertion device integrated into a single unit, thereby again eliminating the need to carry any additional accessories and avoid the difficulty associated with loading the infusion set onto the insertion device at each use.
  • Fig. 38 is a view of an exemplary device 500 utilizing an integrated inserter and set in accordance with a seventh embodiment of the present invention.
  • the device 500 comprises an upper housing 510, from which a trigger 520 extends.
  • a needle hub 540 having a catheter septum 542, catheter 544 and introducer needle 546 are held in an up and retracted position by the trigger 520.
  • the catheter assembly 540 is flexibly connected to the upper housing 510 by a spring 550.
  • a flat coil spring, or similar spring is provided to hold the catheter assembly 540 at a zero energy position within the upper housing as shown in Fig. 39 .
  • the spring 550 permits an axis of motion of the catheter assembly 540 as shown in Fig.
  • a base of the housing 510 can comprise a latch 512 to capture the catheter septum 542 at a lower position, as described in greater detail below.
  • An adhesive liner can be provided to cover an adhesive layer 504, such as a pressure sensitive adhesive (PSA), on the bottom of the device.
  • PSA pressure sensitive adhesive
  • the inserter mechanism travels to one position after activation, and the introducer needle is then retracted with a subsequent step leaving an exposed needle point.
  • the use of a pre-loaded, flat coil spring with a needle hub at a central opening and which is housed in a cylindrical barrel, perpendicular to the direction of motion can achieve placement and retraction with a single step.
  • the spring can drive the introducer needle and catheter into a skin surface, whereupon the introducer needle retracts, or bounces back out of the skin surface due to the design and positioning of the flat coil spring.
  • the introducer needle is retracted back into the cylindrical barrel housing, effectively removing the introducer needle and providing user safety since the introducer needle is not exposed during disposal.
  • the spring 550 is secured between the upper housing 510 and the needle hub 540 at a zero energy position.
  • the needle hub 540 is then releasably secured by the trigger 520 as shown in Fig. 40A .
  • Construction of such a trigger 520 is well known to those skilled in the art and therefore, further description is not provided.
  • the trigger 520 releasably holds the needle hub 540 in an up position, imparting stored energy to the spring 550.
  • the spring 550 urges the needle hub 540 toward the skin surface as shown in Fig. 40B .
  • catheter 544 and introducer needle 546 are driven by the spring 550 toward the skin surface as shown in Figs. 40C and 40D .
  • the spring 550 urges the needle hub 540 and introducer needle 546 away from the skin surface, leaving the catheter septum 542 and catheter 544 in the down position as shown in Fig. 40E .
  • the device will not work statically, and requires pre-positioning at a position XU and release to create momentum. Further, the spring will have momentum losses, which cannot exceed required insertion energy for proper operation.
  • the response of latches 512 at X2 must be faster than the bounce back at X3 due to impact. What will be observed can be shown in Equation (3) below, if latching is provided at insertion,
  • the device 500 has a circular shape, but is not limited thereto.
  • the shape of the device can be configured in any number of shapes, but having a circular portion to permit coil spring operation.
  • a line set 502 can then be attached to the device and can be connected to a medicament pump or other supply vessel.
  • An adhesive liner can be provided to cover an adhesive layer 504, such as a pressure sensitive adhesive (PSA), on the bottom of the device.
  • PSA pressure sensitive adhesive
  • a user removes the adhesive liner from the lower surface to expose the adhesive layer 504 of the bottom of the device.
  • the needle hub 540, catheter septum 542, catheter 544 and introducer needle 546 are retracted into the upper housing 510 and held by the trigger 520.
  • the device 500 can then be secured to an infusion site using the exposed adhesive layer 504. This ensures that the device 500 is fully contacting and adhesively secured to the skin surface before the user performs the deployment of the needle hub 540, catheter septum 542, catheter 544 and introducer needle 546.
  • the user can then press the trigger 520 of the device 500 to release the spring 550 and drive the needle hub 540, catheter septum 542, catheter 544 and introducer needle 546 into position at the infusion site, and which can be held by latches 512 if provided.
  • the continued spring 550 movement toward the zero-energy position drives the needle hub 540 and introducer needle 546 into a retracted position If not already connected, the tube 502 can then be connected to a pump or other medicament supply
  • the seventh embodiment comprises an introducer needle and catheter mounted on the pre-loaded flat coil spring with a hub that is housed within a cylindrical barrel, perpendicular to the direction of motion.
  • the spring releases and drives the introducer needle and catheter into the user's skin, whereupon the introducer needle retracts (i.e., bounces) back out of the skin, due to the design and positioning of the spring, and back into the cylindrical barrel housing, effectively removing the introducer needle and providing patient safety since there is no exposed needle.
  • Such a design provides a one-step motion for insertion and safety, with a simpler design having fewer parts and components.
  • neither inner barrel nor safety spring is required.
  • prior devices require a separate motion to remove the introducer needle and another motion to shield the device for safety. Utilizing a flat coil spring perpendicular to the direction of motion, placed in the correct barrel inner diameter location, enables the device to work in two directions in the same axis, therefore accomplishing insertion and then removal or retraction of the introducer needle.
  • the exemplary embodiments of the present invention described above incorporate hub-integrated insertion in which an introducer needle tip is retracted for comfort, but can remain for support of the catheter.
  • Other exemplary embodiments of the present invention described above also incorporate hub-integrated insertion but wherein a flexible in-dwelling steel needle or catheter can be provided to remain in the skin and exhibit similar beneficial results.
  • a separate or non-integrated inserter can also be used to provide a very low profile hub and set. In this case, the introducer needle and/or driving mechanism can remain with the separate, removable inserter.
  • the device comprises a single-use infusion set and insertion device preassembled into a single unit, thereby again eliminating at least the need to carry and assemble separate accessories, and avoiding the difficulty associated with loading the infusion set into the insertion device at each use.
  • Figs. 41-43 are views of an exemplary device 600 utilizing an inserter and infusion set in accordance with a third embodiment of the present invention.
  • the device 600 comprises an insertion device 610, from which a user push button 620 extends.
  • the insertion device 610 further contains an infusion set 650 at a distal end for placement at an infusion site.
  • a catheter 630 can be extended from a bottom surface of a set hub 640 of the infusion set 650 during activation of the insertion device 610.
  • Fig. 44 is a cross-sectional view of the exemplary device of Fig. 41 , illustrating the components thereof in greater detail.
  • the insertion device 610 contains the infusion set 650 at a distal end for placement.
  • An adhesive pull liner 635 covering an adhesive layer 636 can be provided to seal and secure the distal end of the insertion device 610.
  • the insertion device 610 further comprises an opening at a side surface in which the push button 620 is disposed.
  • the push button 620 is configured to slidably travel substantially parallel to a skin surface from an extended position to a substantially flush position. In doing so, the push button 620 is configured to release a driving mechanism of the insertion device 610 and drive a catheter holder 612 into an infusion set 650 for placement at an infusion site.
  • the core, independent catheter holder 612 is deployed with the catheter 630 into the hub 640, which is secured to the skin surface.
  • an insertion spring mechanism (not shown) is disposed within the insertion device in a loaded state such that the movement of the push button 620 releases the spring and deploys the independent catheter holder 612. Construction of such a driving mechanism is well known to those skilled in the art and therefore, further description is not provided.
  • the insertion device 610 contains the independent catheter holder 612 in a position above the infusion set 650.
  • the independent catheter holder 612 comprises an outer flexible or resilient member 614 surrounding and supporting a main body 618 and catheter 630.
  • the independent catheter holder 612, outer flexible or resilient member 614, main body 618 and catheter 630 are driven downward into the infusion site.
  • the outer flexible or resilient member 614 is centered and held in position by an opening 616 in the hub 640.
  • the opening 616 can comprise a shoulder or detent 624 to assist in capturing and holding the outer flexible or resilient member 614 once in position.
  • the main body 618 has a rounded distal end 626 to self-align with an opening 622 in the hub 640.
  • the catheter 624 is aligned and positioned within the hub 640, but is isolated from movement by the engagement between the flexible or resilient member 614 and the opening 616 in the hub 640.
  • the hub 640 further comprises a tube connection 642 which can be connected with a medicament pump or other supply vessel.
  • the adhesive liner 635 can be provided to cover the adhesive layer 636, such as a pressure sensitive adhesive (PSA), on the bottom of the hub 640.
  • PSA pressure sensitive adhesive
  • Figs. 46A-46F are views of the exemplary device 600 of Fig. 41 in use.
  • a user removes the adhesive liner 635 from the lower surface to expose the adhesive layer 636 of the bottom of the device 600.
  • the hub 640 of the device 600 can then be secured to an infusion site using the exposed adhesive layer 636 as shown in Fig. 46B . This ensures that the hub 640 of the device 600 is fully contacting and adhesively secured to the skin surface before the user performs the deployment of the catheter 630.
  • the user can then press the button 620 of the device 600 to insert the introducer needle and catheter, or a self-placing, in-dwelling catheter 630 in a single motion as shown in Fig. 46C .
  • the insertion device 610 can then be removed and the tube 642 can then be connected to an insulin infusion pump or other medicament supply 644 as shown in Figs. 46D-46F .
  • the user can attach the complete device to the skin surface and then deploy the independent catheter holder and catheter, preventing any bunching of the adhesive when attached as well as ensuring that the set hub is fully contacting and adhesively secured to the skin before the catheter is inserted. This also ensures that the catheter is inserted at the correct depth.
  • the exemplary device further provides a "floating catheter" feature of the independent catheter holder 612 wherein the catheter assembly is flexibly or resiliently suspended or supported in the hub to dampen motion due to body movement or accidental bumps and/or tubing tugs.
  • the device uses an automatic method of deployment as the user only needs to push the button of the device to insert the catheter.
  • an introducer needle, catheter, and adhesive are all deployed at substantially the same time and during such ballistic insertion, there is a high-speed contact of the adhesive pad while the introducer needle and the catheter are being inserted which may result in partially inserted catheters and/or incomplete adhesion.
  • the exemplary eighth embodiment of the present invention eliminates the potential of partial insertion of the catheter and/or incomplete adhesion, since the system and method first ensures that the hub of the set is fully contacting and adhesively secured to the skin surface and then performs the deployment of the catheter. Further, the catheter assembly is configured to "float" in the hub, which serves to dampen motion due to body movement or accidental bumps and/or tubing tugs.
  • the exemplary eighth embodiment of the present invention significantly reduces the steps required to insert the infusion set since the user is not required to load the infusion set into the inserter device. Further, the flexible catheter including sharpened tip is hidden from the user prior to use and insertion, which makes the device more safe and appealing to users who are uncomfortable with needles.
  • the device is configured for the user to attach the device to the skin surface in a first step, then deploy the introducer needle in a second step, thereby preventing any bunching of the adhesive when attached as well as ensuring that the set hub is fully contacting the skin before the introducer needle is inserted. This also ensures that the catheter is inserted at the correct depth. Further, the catheter is configured to "float" in the hub which serves to dampen motion due to body movement and/or accidental bumps to the hub and/or tubing tugs.
  • the housings, hubs and other elements can be constructed of molded plastic materials, polycarbonate, thermoplastic polymers such as polyethylene terephthalate (PET and PETG), or similar materials.
  • Springs and introducer needles can be constructed of stainless steel or similar materials.
  • one or more of the exemplary embodiments of the present invention can be provided with a skin contacting adhesive layer and backing. Precise insertion is achieved by first securing the infusion set hub to the infusion site via the adhesive, which permits the user to activate the inserter or place the catheter as described above at the proper alignment. In doing so, the introducer needle is driven into the skin surface at a controlled high rate of speed to minimize the risk of tenting at introducer needle insertion. Further, the adhesive at or very near the insertion site secures the skin surface and minimizes tenting of the skin surface during insertion.
  • the catheter In current infusion sets which deliver insulin or other medicament to the subcutaneous layer, the catheter is not isolated from any undesired outside forces, which may cause pain when translated to the catheter which then moves within the skin. Also, other devices face problems of premature or unintended catheter removal when the device is bumped, if the catheter is not isolated from the outside forces.
  • the catheter can isolated from outside forces by at least one flexible or resilient feature.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Claims (14)

  1. Dispositif de perfusion (200) comprenant un dispositif d'insertion qui peut insérer un cathéter dans une surface de la peau, comprenant :
    un boîtier de dispositif de perfusion (210), comprenant un cathéter (244) et un dispositif d'entraînement pour placer ledit cathéter dans une surface de la peau ; et
    une base de dispositif de perfusion (230), comprenant au moins une couche adhésive (204) pour fixer de manière amovible ladite base de dispositif de perfusion à ladite surface de la peau,
    caractérisé par
    une aiguille d'introduction (246) et un septum de cathéter (242), où ledit dispositif d'entraînement comprend un raccord d'aiguille rotatif (216) configuré pour tourner dans ledit boîtier de dispositif de perfusion (210) sous l'action d'une force appliquée par un premier ressort (212) et pour presser ladite aiguille d'introduction et ledit cathéter dans ladite surface de la peau et où ledit raccord d'aiguille est configuré pour tourner davantage dans ledit boîtier de dispositif de perfusion sous l'action d'une force appliquée par ledit premier ressort (212) et pour rétracter ladite aiguille d'introduction dudit cathéter.
  2. Dispositif de perfusion tel que revendiqué dans la revendication 1, comprenant en outre :
    une aiguille d'introduction et un septum de cathéter, où ledit dispositif d'entraînement comprend :
    un bouton poussoir configuré pour se déplacer essentiellement perpendiculairement à ladite surface de la peau et presser ledit septum de cathéter vers ladite surface de la peau et insérer ladite aiguille d'introduction et ledit cathéter dans ladite surface de la peau, où ledit bouton poussoir est configuré pour se rétracter de ladite surface de la peau lors de la libération dudit bouton poussoir et rétracter ladite aiguille d'introduction dans ledit cathéter.
  3. Dispositif de perfusion tel que revendiqué dans la revendication 1, dans lequel ledit boîtier de dispositif de perfusion comprend une fenêtre de visualisation.
  4. Dispositif de perfusion tel que revendiqué dans la revendication 2, comprenant en outre :
    un ressort de rétraction configuré pour rétracter automatiquement ladite aiguille d'introduction lors de la libération, où ledit bouton poussoir est configuré pour libérer ledit ressort de rétraction lorsque ladite aiguille d'introduction et ledit cathéter sont insérés dans ladite surface de la peau.
  5. Dispositif de perfusion tel que revendiqué dans la revendication 2, dans lequel :
    ladite base comprend une ouverture de septum pour recevoir en coulissement ledit septum de cathéter, ladite ouverture de septum comprenant une ouverture de trajet de fluide ;
    ledit septum de cathéter comprend une ouverture de trajet de fluide ; et
    ledit cathéter comprend une ouverture de trajet de fluide, où lesdites ouvertures de trajet de fluide sont alignées lorsque ladite aiguille d'introduction et ledit cathéter sont insérés dans ladite surface de la peau.
  6. Dispositif de perfusion tel que revendiqué dans la revendication 2, dans lequel ledit bouton poussoir comprend :
    un segment de boîtier supérieur flexible ayant une première forme lorsqu'il est relâché et une deuxième forme lorsqu'il est comprimé, où ledit boîtier supérieur flexible est configuré pour se déplacer essentiellement perpendiculairement à ladite surface de la peau et pour presser ledit septum de cathéter vers ladite surface de la peau et insérer ladite aiguille d'introduction et ledit cathéter dans ladite surface de la peau lorsqu'il est comprimé, et où ledit boîtier supérieur flexible est configuré pour rétracter ladite aiguille d'introduction lorsqu'il est relâché.
  7. Dispositif de perfusion tel que revendiqué dans la revendication 2, dans lequel ladite base de dispositif de perfusion comprend au moins l'un parmi:
    un verrou de retenue de cathéter pour capturer ledit septum de cathéter lorsque ladite aiguille d'introduction et ledit cathéter sont insérés dans ladite surface de la peau ;
    un verrou de retenue de corps pour capturer ledit segment de boîtier supérieur flexible lorsque ladite aiguille d'introduction est rétractée ; et
    un verrou de retenue de bouton pour capturer ledit bouton poussoir lorsque ladite aiguille d'introduction et ledit cathéter sont insérés dans ladite surface de la peau.
  8. Dispositif de perfusion tel que revendiqué dans la revendication 1, comprenant en outre :
    un trajet de cathéter incurvé, où ledit dispositif d'entraînement comprend un bouton poussoir configuré pour se déplacer essentiellement parallèlement à ladite surface de la peau et presser ledit cathéter à travers ledit trajet de cathéter incurvé et dans ladite surface de la peau, où ledit cathéter comprend une canule à demeure.
  9. Dispositif de perfusion tel que revendiqué dans la revendication 1, dans lequel ledit dispositif d'entraînement comprend :
    un anneau à came rotatif configuré pour tourner dans ledit boîtier de dispositif de perfusion et presser ledit cathéter dans ladite surface de la peau.
  10. Dispositif de perfusion tel que revendiqué dans la revendication 1, comprenant en outre :
    une aiguille d'introduction, où ledit dispositif d'entraînement comprend :
    un anneau à came rotatif configuré pour tourner dans ledit boîtier de dispositif de perfusion et presser ladite aiguille d'introduction et ledit cathéter dans ladite surface de la peau, et pour tourner davantage dans ledit boîtier de dispositif de perfusion et rétracter ladite aiguille d'introduction dudit cathéter.
  11. Dispositif de perfusion tel que revendiqué dans la revendication 1, dans lequel :
    ladite base comprend une ouverture de septum pour recevoir en coulissement ledit septum de cathéter, ladite ouverture de septum comprenant une ouverture de trajet de fluide ;
    ledit septum de cathéter comprend une ouverture de trajet de fluide ; et
    ledit cathéter comprend une ouverture de trajet de fluide, où lesdites ouvertures de trajet de fluide sont alignées lorsque ladite aiguille d'introduction et ledit cathéter sont insérés dans ladite surface de la peau.
  12. Dispositif de perfusion tel que revendiqué dans la revendication 1, comprenant en outre :
    une aiguille d'introduction et un septum de cathéter, où ledit dispositif d'entraînement comprend un ressort hélicoïdal disposé essentiellement parallèlement à ladite surface de la peau et ayant ladite aiguille d'introduction, ledit septum de cathéter et ledit cathéter disposés dans une ouverture centrale,
    dans lequel ledit ressort hélicoïdal est configuré pour tourner et entraîner ladite aiguille d'introduction, ledit septum de cathéter et ledit cathéter essentiellement perpendiculairement à ladite surface de la peau et presser ledit septum de cathéter vers ladite surface de la peau et insérer ladite aiguille d'introduction et ledit cathéter dans ladite surface de la peau et pour tourner davantage afin de rétracter ladite aiguille d'introduction dudit cathéter.
  13. Dispositif de perfusion tel que revendiqué dans la revendication 12, dans lequel ladite base de dispositif de perfusion comprend au moins un verrou de retenue de cathéter pour capturer ledit septum de cathéter lorsque ladite aiguille d'introduction et ledit cathéter sont insérés dans ladite surface de la peau.
  14. Dispositif de perfusion tel que revendiqué dans la revendication 1, dans lequel :
    ledit dispositif d'entraînement comprend un bouton poussoir configuré pour se déplacer essentiellement parallèlement à ladite surface de la peau et libérer ledit cathéter et insérer ledit cathéter dans ladite surface de la peau ;
    ledit cathéter comprend un porte-cathéter flexible, où ledit cathéter est couplé de manière flexible à ladite base par l'intermédiaire dudit porte-cathéter flexible ; et
    ladite base comprend une ouverture de cathéter pour recevoir en coulissement et aligner ledit cathéter, où ledit porte-cathéter flexible est capturé par ladite ouverture de cathéter.
EP12744352.1A 2011-02-09 2012-02-08 Dispositif de perfusion sous-cutané Active EP2673023B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP19157528.1A EP3542852B1 (fr) 2011-02-09 2012-02-08 Dispositif de perfusion sous-cutanée

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161441265P 2011-02-09 2011-02-09
PCT/US2012/000069 WO2012108955A2 (fr) 2011-02-09 2012-02-08 Dispositif de perfusion sous-cutané

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP19157528.1A Division EP3542852B1 (fr) 2011-02-09 2012-02-08 Dispositif de perfusion sous-cutanée
EP19157528.1A Division-Into EP3542852B1 (fr) 2011-02-09 2012-02-08 Dispositif de perfusion sous-cutanée

Publications (3)

Publication Number Publication Date
EP2673023A2 EP2673023A2 (fr) 2013-12-18
EP2673023A4 EP2673023A4 (fr) 2016-06-29
EP2673023B1 true EP2673023B1 (fr) 2019-04-03

Family

ID=46639118

Family Applications (2)

Application Number Title Priority Date Filing Date
EP19157528.1A Active EP3542852B1 (fr) 2011-02-09 2012-02-08 Dispositif de perfusion sous-cutanée
EP12744352.1A Active EP2673023B1 (fr) 2011-02-09 2012-02-08 Dispositif de perfusion sous-cutané

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP19157528.1A Active EP3542852B1 (fr) 2011-02-09 2012-02-08 Dispositif de perfusion sous-cutanée

Country Status (7)

Country Link
US (3) US10342918B2 (fr)
EP (2) EP3542852B1 (fr)
JP (1) JP6006239B2 (fr)
CN (1) CN203898932U (fr)
CA (3) CA3175799A1 (fr)
ES (1) ES2732080T3 (fr)
WO (1) WO2012108955A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4494673A1 (fr) * 2023-07-21 2025-01-22 Medtronic MiniMed, Inc. Dispositif d'infusion de médicament

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1762259E (pt) 2005-09-12 2010-12-10 Unomedical As Insersor para um conjunto de infusão com uma primeira e uma segunda unidades de mola
EP2626093B1 (fr) * 2008-08-28 2014-02-12 Medingo Ltd. Dispositif pour l'absorption sous-cutanée accrue d'insuline
WO2011121023A1 (fr) 2010-03-30 2011-10-06 Unomedical A/S Dispositif médical
US8915879B2 (en) 2010-09-24 2014-12-23 Perqflo, Llc Infusion pumps
US8905972B2 (en) 2010-11-20 2014-12-09 Perqflo, Llc Infusion pumps
EP3677295B1 (fr) * 2011-02-09 2024-08-28 Becton, Dickinson and Company Dispositif d'insertion de ressort de torsion autocontenu pour ensemble de perfusion d'administration de médicament
US10194938B2 (en) 2011-03-14 2019-02-05 UnoMedical, AS Inserter system with transport protection
US8882711B2 (en) 2011-09-30 2014-11-11 Animas Corporation Insertion device for a medical conduit
WO2013050277A1 (fr) 2011-10-05 2013-04-11 Unomedical A/S Introducteur pour insertion simultanée de plusieurs éléments transcutanés
EP2583715A1 (fr) 2011-10-19 2013-04-24 Unomedical A/S Système de tube de perfusion et procédé de fabrication
JP6193255B2 (ja) 2011-12-07 2017-09-06 ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ 針シールドアセンブリ及びその使用のための点滴装置
CA3043584C (fr) 2011-12-07 2021-02-16 Becton, Dickinson And Company Dispositif d'infusion avec raccord de liquide amovible
USD754842S1 (en) * 2012-12-07 2016-04-26 Becton, Dickinson And Company Infusion set needle guard
USD747459S1 (en) * 2012-12-07 2016-01-12 Becton, Dickinson And Company Infusion set assembly
USD754843S1 (en) * 2012-12-07 2016-04-26 Becton, Dickinson And Company Infusion set assembly
USD756504S1 (en) * 2012-12-07 2016-05-17 Becton, Dickinson And Company Infusion set base
USD747457S1 (en) * 2012-12-07 2016-01-12 Becton, Dickinson And Company Infusion set needle guard
USD747458S1 (en) * 2012-12-07 2016-01-12 Becton, Dickinson And Company Infusion set insertion needle assembly
USD747456S1 (en) * 2012-12-07 2016-01-12 Becton, Dickinson And Company Infusion set assembly
US9821113B2 (en) * 2013-03-15 2017-11-21 Becton, Dickinson And Company Automatic angled infusion set assembly
WO2015164649A1 (fr) * 2014-04-24 2015-10-29 Becton, Dickinson And Company Dispositif de perfusion de fluide
WO2015164651A1 (fr) * 2014-04-24 2015-10-29 Becton, Dickinson And Company Dispositif d'introduction de cathéter
US10195342B2 (en) 2014-04-24 2019-02-05 Becton, Dickinson And Company Cannula deployment mechanism
JP6618928B2 (ja) * 2014-04-24 2019-12-11 ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ カテーテル挿入装置及びカテーテルを挿入する方法
US12178992B2 (en) 2014-09-30 2024-12-31 Medtronic Minimed, Inc. Different disposable assemblies for the same reusable assembly
US10159786B2 (en) 2014-09-30 2018-12-25 Perqflo, Llc Hybrid ambulatory infusion pumps
KR102615656B1 (ko) * 2015-02-10 2023-12-18 암겐 인코포레이티드 약물 전달 펌프의 회전 편향식 삽입 기구
WO2016133789A2 (fr) 2015-02-18 2016-08-25 Perqflo, Llc Pompe à perfusion ambulatoire et ensembles réservoirs à utiliser avec celle-ci
CN113289133A (zh) * 2015-03-09 2021-08-24 安姆根有限公司 用于药物递送泵的驱动机构
WO2016196934A1 (fr) 2015-06-04 2016-12-08 Medimop Medical Projects Ltd. Introduction d'une cartouche pour dispositif d'administration de médicament
WO2017053572A1 (fr) * 2015-09-22 2017-03-30 Thomas Jefferson University Cathéter de perfusion d'insuline sous-cutanée continue
US20170203053A1 (en) * 2016-01-19 2017-07-20 Joseph Choate Burkett Visual-Assisted Insertion Device
US11357912B2 (en) 2016-01-19 2022-06-14 Unomedical A/S Cannula and infusion devices
WO2017139003A1 (fr) * 2016-02-10 2017-08-17 Unitract Syringe Pty Ltd. Dispositif d'administration de médicament
EP3413954A1 (fr) 2016-02-12 2018-12-19 Perqflo, LLC Pompes à perfusion ambulatoires et ensembles à utiliser avec celle-ci
JOP20170042B1 (ar) * 2016-02-12 2022-09-15 Amgen Inc وسيلة توصيل عقار، طريقة تصنيعه وطريقة استخدامه
KR101754981B1 (ko) 2016-02-29 2017-07-06 중소기업은행 약액 주입 장치
KR101764813B1 (ko) * 2016-02-29 2017-08-03 중소기업은행 커버체 및 이를 구비한 약액 주입 장치
EP3834864A1 (fr) 2016-04-08 2021-06-16 Amgen Inc. Dispositif d'administration de médicaments, procédé de fabrication et procédé d'utilisation
EP3243539B1 (fr) * 2016-05-11 2020-04-08 Becton, Dickinson and Company Module de sécurité pour aiguille d'insertion
US10603445B2 (en) 2016-06-09 2020-03-31 Becton, Dickinson And Company Needle actuator assembly for drug delivery system
WO2018029238A1 (fr) * 2016-08-12 2018-02-15 Sanofi-Aventis Deutschland Gmbh Dispositif d'administration de médicaments.
KR101928297B1 (ko) * 2016-09-08 2018-12-12 이오플로우(주) 약액 주입장치
DK3519018T3 (da) * 2016-09-27 2021-06-14 Sanofi Aventis Deutschland Medikamentadministrationsanordning
EP3354303B1 (fr) * 2017-01-31 2020-01-08 Société Industrielle de Sonceboz S.A. Dispositif d'administration d'un medicament
WO2018184012A1 (fr) 2017-03-31 2018-10-04 Capillary Biomedical, Inc. Dispositif de perfusion à insertion hélicoïdale
EP3630226A1 (fr) 2017-05-30 2020-04-08 West Pharma. Services Il, Ltd. Train d'entraînement modulaire pour injecteur pouvant être porté
US11260171B2 (en) * 2017-07-04 2022-03-01 Medtronic Minimed, Inc. Ambulatory infusion pumps and assemblies for use with same
CN113274578B (zh) 2017-07-07 2022-06-03 纽罗德姆有限公司 用于流体药物的皮下输送的设备
US20230123806A1 (en) 2017-07-07 2023-04-20 Neuroderm, Ltd. Device for subcutaneous delivery of fluid medicament
WO2019032384A1 (fr) * 2017-08-10 2019-02-14 West Pharma. Services IL, Ltd. Ensemble bouton d'activation et mécanisme d'insertion d'aiguille d'injection pour injecteur
CN107320811A (zh) * 2017-08-15 2017-11-07 郑州蒙纳瑞医疗设备有限公司 一种可重复利用的留置式皮下输液器
WO2019049628A1 (fr) * 2017-09-08 2019-03-14 テルモ株式会社 Dispositif de perforation
US10632280B2 (en) * 2017-09-15 2020-04-28 Neosinus Health Inc. Devices and methods for delivering fluid to a nasal cavity
US10869961B2 (en) 2017-11-06 2020-12-22 Sorrel Medical Ltd. Local disinfection for drug delivery system
US11857767B2 (en) 2017-12-22 2024-01-02 West Pharma. Services IL, Ltd. Injector usable with different dimension cartridges
US10980938B2 (en) * 2018-03-08 2021-04-20 Flex Ltd. Double action rigid fluid path connector
KR102111732B1 (ko) * 2018-08-14 2020-05-15 이오플로우(주) 니들 어셈블리 및 이를 포함하는 약물 주입 장치
EP3846877A4 (fr) * 2018-09-04 2022-06-15 Biolark, Inc. Ensemble de perfusion à usage prolongé destiné à un usage médical
WO2020058069A1 (fr) * 2018-09-22 2020-03-26 Shl Medical Ag Ensemble d'insertion rétraction d'aiguille d'injecteur
ES2986346T3 (es) 2018-10-05 2024-11-11 Lts Device Tech Ltd Secuencia de activación
CA3208266C (fr) 2019-02-22 2024-04-16 Deka Products Limited Partnership Ensemble de perfusion, systemes d'ensemble d'insertion et procedes
BR112021023304A2 (pt) 2019-05-20 2022-02-01 Unomedical As Dispositivo de infusão rotativo e métodos do mesmo
US11052205B2 (en) 2019-06-11 2021-07-06 Neosinus Health Inc Devices and methods for delivering fluid to a nasal cavity
WO2022047199A1 (fr) 2020-08-28 2022-03-03 Capillary Biomedical, Inc. Ensemble de perfusion d'insuline
US11951281B2 (en) 2020-11-11 2024-04-09 Medtronic Minimed, Inc. Fluid conduit insertion devices
US20220143306A1 (en) * 2020-11-11 2022-05-12 Medtronic Minimed, Inc. Torsional insertion devices
EP4274644A4 (fr) 2021-01-05 2025-01-15 Becton Dickinson Co Dispositif d'administration de médicament avec raccord d'aiguille
CN117836023A (zh) 2021-07-23 2024-04-05 康沃特克有限公司 具有穿刺机构的端口
CN114306809B (zh) * 2021-12-31 2024-11-22 深圳市阿瑞医疗电子有限公司 一种平衡式留置针组件及贴敷式药液输注系统
CN114344617B (zh) * 2022-01-13 2023-09-22 上海旭润医学科技有限责任公司 一种用于贴敷式连续皮下给药系统的辅助进针装置
USD1043976S1 (en) 2022-08-26 2024-09-24 Deka Products Limited Partnership Fluid transfer connector
USD1057941S1 (en) 2022-08-26 2025-01-14 Deka Products Limited Partnership Patient care assembly component
WO2024173658A2 (fr) * 2023-02-17 2024-08-22 Aita Bio Inc. Ensemble de rétraction d'aiguille pour un dispositif d'administration d'insuline

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3918355A (en) * 1972-08-24 1975-11-11 Robert L Weber Infusion apparatus and method
US5129884A (en) 1990-01-16 1992-07-14 Dysarz Edward D Trap in barrel one handed retracted intervenous catheter device
US5993470A (en) 1992-09-15 1999-11-30 Yoon; Inbae Universal handle for medical instruments
US6607509B2 (en) 1997-12-31 2003-08-19 Medtronic Minimed, Inc. Insertion device for an insertion set and method of using the same
US6485461B1 (en) 2000-04-04 2002-11-26 Insulet, Inc. Disposable infusion device
US6740059B2 (en) 2000-09-08 2004-05-25 Insulet Corporation Devices, systems and methods for patient infusion
AU2001296588B2 (en) 2000-10-04 2006-06-08 Insulet Corporation Data collection assembly for patient infusion system
ATE352333T1 (de) 2000-11-09 2007-02-15 Insulet Corp Gerät zur transkutanen abgabe von medikamenten
IL141574A0 (en) 2001-02-21 2002-03-10 Serpomed Ltd Compact catheter insertion apparatus
US6960192B1 (en) 2002-04-23 2005-11-01 Insulet Corporation Transcutaneous fluid delivery system
US20040010207A1 (en) 2002-07-15 2004-01-15 Flaherty J. Christopher Self-contained, automatic transcutaneous physiologic sensing system
US7128727B2 (en) 2002-09-30 2006-10-31 Flaherty J Christopher Components and methods for patient infusion device
US7144384B2 (en) 2002-09-30 2006-12-05 Insulet Corporation Dispenser components and methods for patient infusion device
WO2004030726A1 (fr) 2002-10-07 2004-04-15 Novo Nordisk A/S Dispositif a aiguilles comportant une pluralite d'aiguilles
EP1624914B1 (fr) * 2003-05-08 2008-04-16 Novo Nordisk A/S Module d'insertion d'aiguille interne
US6926694B2 (en) 2003-05-09 2005-08-09 Medsolve Technologies, Llc Apparatus and method for delivery of therapeutic and/or diagnostic agents
DE20320207U1 (de) 2003-06-12 2004-10-14 Disetronic Licensing Ag Insertionsvorrichtung für Infusionssets
EP1804859A1 (fr) 2004-09-22 2007-07-11 Novo Nordisk A/S Dispositif medical avec moyen d'insertion de canule
CN101072597B (zh) 2004-12-10 2010-06-16 优诺医疗有限公司 插入器
US9636450B2 (en) 2007-02-19 2017-05-02 Udo Hoss Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
EP1848476A1 (fr) 2005-01-24 2007-10-31 Novo Nordisk A/S Dispositif transcutane
WO2006102412A2 (fr) 2005-03-21 2006-09-28 Abbott Diabetes Care, Inc. Procede et systeme permettant d'obtenir un systeme de controle de substance a analyser et de perfusion de medicament integre
ITVI20050152A1 (it) 2005-05-20 2006-11-21 Tecres Spa Cartuccia per la conservazione e l'erogazione sterile di un composto bifasico, particolarmente per una resina acrilica
TWI257999B (en) * 2005-07-29 2006-07-11 Quanta Display Inc Device for detecting a cracked substrate
PT1762259E (pt) 2005-09-12 2010-12-10 Unomedical As Insersor para um conjunto de infusão com uma primeira e uma segunda unidades de mola
JP5137854B2 (ja) 2006-02-09 2013-02-06 デカ・プロダクツ・リミテッド・パートナーシップ 流体送達システムおよび方法
US7731118B2 (en) * 2006-03-29 2010-06-08 Martin-Baker Aircraft Co., Ltd. Acceleration sensor
EP2032188A1 (fr) 2006-06-06 2009-03-11 Novo Nordisk A/S Ensemble constitué d'un dispositif conçu pour être placé sur la peau et d'un emballage correspondant
US7682338B2 (en) 2006-08-23 2010-03-23 Medtronic Minimed, Inc. Infusion medium delivery system, device and method with needle inserter and needle inserter device and method
US20080195045A1 (en) 2007-02-09 2008-08-14 Lanigan Richard J Automated insertion assembly
ATE477011T1 (de) 2007-03-14 2010-08-15 Hoffmann La Roche Insertionsvorrichtung für einen insertionskopf, insbesondere für ein infusionsset
US20100152674A1 (en) 2007-04-30 2010-06-17 Medtronic Minimed, Inc Needle inserting and fluid flow connection for infusion medium delivery system
JP5102350B2 (ja) * 2007-04-30 2012-12-19 メドトロニック ミニメド インコーポレイテッド リザーバ充填／気泡管理／注入媒体送給システムおよび該システムを用いる方法
US20080312558A1 (en) 2007-06-15 2008-12-18 Peter Krulevitch Flexible conduit insertion medical device
EP2155296B1 (fr) 2007-06-20 2019-08-28 Unomedical A/S Dispositif d'insertion pour aiguille avec retraction automatique de l'aguille comprenant seulement un ressort
CN101754779B (zh) * 2007-07-18 2012-09-05 优诺医疗有限公司 具有受控的加速度的插入装置
US7828771B2 (en) * 2007-07-26 2010-11-09 Entra Pharmaceuticals, Inc. Systems and methods for delivering drugs
US9968742B2 (en) 2007-08-29 2018-05-15 Medtronic Minimed, Inc. Combined sensor and infusion set using separated sites
EP2200677A1 (fr) 2007-09-17 2010-06-30 ICU Medical, Inc. Dispositifs d'insertion pour dispositifs de perfusion
DE102007049446A1 (de) * 2007-10-16 2009-04-23 Cequr Aps Katheter-Einführeinrichtung
IL194805A0 (en) 2007-10-29 2009-08-03 Lifescan Inc Medical device flexible conduit and method of manufacture
ES2688062T3 (es) 2009-01-12 2018-10-30 Becton, Dickinson And Company Set de infusión y/o bomba de parches que tiene al menos uno de un catéter rígido de permanencia interna con rasgos flexibles y/o una conexión de catéter flexible
US9375529B2 (en) 2009-09-02 2016-06-28 Becton, Dickinson And Company Extended use medical device
US10092691B2 (en) 2009-09-02 2018-10-09 Becton, Dickinson And Company Flexible and conformal patch pump
CA2766693A1 (fr) * 2010-03-24 2011-09-29 Abbott Diabetes Care Inc. Appareils d'insertion de dispositifs medicaux et procedes d'insertion et d'utilisation de dispositifs medicaux
US8795230B2 (en) * 2010-11-30 2014-08-05 Becton, Dickinson And Company Adjustable height needle infusion device
WO2012141759A1 (fr) 2011-03-03 2012-10-18 Becton Dickinson And Company Dispositif d'insertion à ressort compact pour tubulure de perfusion d'administration de médicament
EP2495001A1 (fr) 2011-03-03 2012-09-05 Debiotech S.A. Inserteur de canule
EP4201327B1 (fr) 2012-03-30 2024-06-19 Insulet Corporation Dispositif d'administration de fluide avec outil d'accès transcutané, mécanisme d'insertion et contrôle de glycémie destine à être utilisé avec le dispositif

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4494673A1 (fr) * 2023-07-21 2025-01-22 Medtronic MiniMed, Inc. Dispositif d'infusion de médicament

Also Published As

Publication number Publication date
WO2012108955A3 (fr) 2013-11-07
US20140058353A1 (en) 2014-02-27
EP2673023A4 (fr) 2016-06-29
CA2826094C (fr) 2020-11-10
CA3092628C (fr) 2022-12-13
CA3175799A1 (fr) 2012-08-16
ES2732080T3 (es) 2019-11-20
US20200001005A1 (en) 2020-01-02
JP6006239B2 (ja) 2016-10-12
CA2826094A1 (fr) 2012-08-16
US11878143B2 (en) 2024-01-23
CN203898932U (zh) 2014-10-29
JP2014510571A (ja) 2014-05-01
EP3542852C0 (fr) 2024-07-10
WO2012108955A2 (fr) 2012-08-16
CA3092628A1 (fr) 2012-08-16
EP3542852A1 (fr) 2019-09-25
EP2673023A2 (fr) 2013-12-18
US10342918B2 (en) 2019-07-09
EP3542852B1 (fr) 2024-07-10
US20240148964A1 (en) 2024-05-09

Similar Documents

Publication Publication Date Title
US20240148964A1 (en) Subcutaneous infusion device
JP7203789B2 (ja) 薬物注入装置のための一体型ばね作動式衝撃挿入
EP2673030B1 (fr) Dispositif d'insertion autonome pour tubulure de perfusion pour administration de médicament
US10828418B2 (en) Slide-activated angled inserter and cantilevered ballistic insertion for intradermal drug infusion
KR20210013093A (ko) 주사기 니들 삽입 및 후퇴 조립체
EP4000667A1 (fr) Dispositifs d'insertion torsionnels

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130828

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 39/02 20060101AFI20131120BHEP

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602012058575

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61M0005140000

Ipc: A61M0039020000

A4 Supplementary search report drawn up and despatched

Effective date: 20160530

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 5/142 20060101ALI20160523BHEP

Ipc: A61M 5/158 20060101ALI20160523BHEP

Ipc: A61M 39/02 20060101AFI20160523BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BECTON, DICKINSON AND COMPANY

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20180904

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1114983

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190415

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602012058575

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20190403

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1114983

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190803

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190703

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2732080

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20191120

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190703

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190704

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190803

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602012058575

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

26N No opposition filed

Effective date: 20200106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200229

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200208

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200229

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200229

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200229

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190403

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20240301

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240123

Year of fee payment: 13

Ref country code: GB

Payment date: 20240123

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20240123

Year of fee payment: 13

Ref country code: FR

Payment date: 20240123

Year of fee payment: 13